Skip to main content
OpenTrials

Clinical trial condition

Parkinson Disease 4, Autosomal Dominant Lewy Body

Explore clinical trials studying Parkinson Disease 4, Autosomal Dominant Lewy Body. Study availability and eligibility vary by location and protocol.

226 public trials 33 recruiting studies
Refine in advanced search Browse all conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body trial results

Completed

Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)

NCT03924856

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations
  • Scripps MD Anderson ( Site 0010) La Jolla, California, United States
  • Providence Saint John's Health Center ( Site 0075) Santa Monica, California, United States
  • Georgetown University Medical Center ( Site 0022) Washington D.C., District of Columbia, United States
  • AdventHealth Orlando-AdventHealth Medical Group Hematology & Oncology at Orlando ( Site 0005) Orlando, Florida, United States
View all 175 locations
View Trial Details
Completed

Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)

NCT04210115

Conditions
Adenocarcinoma Of Esophagus, Carcinoma, Carcinoma, Squamous Cell, +17 more
Locations
  • MemorialCare Health System - Long Beach Medical Center-Oncology ( Site 0691) Long Beach, California, United States
  • Columbus Regional Research Institute ( Site 0047) Columbus, Georgia, United States
  • University of Kansas Cancer Center ( Site 0023) Westwood, Kansas, United States
  • Cancer Center of Kansas ( Site 0058) Wichita, Kansas, United States
View all 170 locations
View Trial Details
Completed

Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-014/E7080-G000-320/LEAP-014)

NCT04949256

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +14 more
Locations
  • City of Hope ( Site 0102) Duarte, California, United States
  • MedStar Washington Hospital Center ( Site 0186) Washington D.C., District of Columbia, United States
  • James Graham Brown Cancer Center ( Site 0117) Louisville, Kentucky, United States
  • Norton Cancer Institute ( Site 0116) Louisville, Kentucky, United States
View all 198 locations
View Trial Details

Related conditions